Singapore's pharmaceutical companies are anxious about new U.S. tariffs on branded drugs. Deputy PM Gan Kim Yong seeks clarity on tariff exemptions as firms plan U.S. expansions. Can they remain competitive?
In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
